Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Acorda Therapeutics Inc (NASDAQ:ACOR)

25.40
Delayed Data
As of Mar 24
 0.00 / 0.00%
Today’s Change
16.40
Today|||52-Week Range
33.00
+35.11%
Year-to-Date

Stock Price Forecast

The 10 analysts offering 12-month price forecasts for Acorda Therapeutics Inc have a median target of 31.00, with a high estimate of 60.00 and a low estimate of 22.00. The median estimate represents a +22.05% increase from the last price of 25.40.

Analyst Recommendations

The current consensus among 11 polled investment analysts is to Buy stock in Acorda Therapeutics Inc. This rating has held steady since March, when it was upgraded from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.09
Sales
$128.5M
Reporting Date
Jan 09

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 82.86%
 
 
 
 
 
 
Growthannually 316.74%
 
 
 
 
 
 

Sales

Growthquarterly -8.63%
 
 
 
 
 
 
Growthannually 7.87%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.